Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1

Sponsor
Anglia Ruskin University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05476705
Collaborator
Pharmacy Research UK (Other), University of Manchester (Other), Ashford and St. Peter's Hospitals NHS Trust (Other)
110
12

Study Details

Study Description

Brief Summary

Up to a third of patients who visit emergency departments (EDs) do so because they have an issue with medicines prescribed by their doctor or purchased over the counter. For example, some patients might experience side effects (e.g., sickness), whereas others may feel their prescribed medicine is not working and want an alternative. While some patients who visit EDs know they have a problem with their medication, some are not aware. Furthermore, drug-related problems (DRPs) may not be identified by ED triage systems which are used to sort patients' priority for treatment. The currently used system in the UK (Manchester Triage System) mentions drugs infrequently and does not support the identification of the most common DRPs. For this project, DRPs include medication errors, adverse drug events, and adverse drug reactions. This project aims to revise the triage system to support the discovery of patients' medication problems when they are triaged by a nurse upon arrival to the ED.

After identification, problems with a patient's medication should be dealt with by the healthcare professional who is most appropriate to manage that particular issue. For example, a patient who has been prescribed a new medicine but already takes 20 medicines will likely benefit from a review by a pharmacist in the ED. This project will aim to support the management of patients who might benefit from care provided by pharmacists by providing them with this care.

As well as ensuring medication problems are identified at triage, and that pharmacists are involved in helping to deal with those problems, this project will also try to understand how we can investigate how pharmacists actually make a difference to the care of ED patients.

A multi-step approach (Stages A-F) is proposed to answer the question "How can patient DRPs be identified, triaged and managed in the ED?" In summary, the steps include: STAGE A, a systematic review and scoping survey; STAGE B, researcher visits to ED sites to shadow ED staff; STAGE C, Interviews with healthcare professionals (including those shadowed in STAGE

  1. to validate findings of site visits and explore topics in more depth; STAGE D, developing additional drug-related content for the Manchester Triage System; STAGE E, involving a panel of experts in a RAND appropriateness method to rate the content developed in STAGE D; STAGE F, testing the revised triage system for a future pilot study involving interviews with staff visited in STAGE B.
Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    110 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Right Place, Right Practitioner, Right Time: Development of Emergency Department Triage to Support the Identification and Management of Drug Related Problems
    Anticipated Study Start Date :
    Sep 1, 2022
    Anticipated Primary Completion Date :
    Sep 1, 2023
    Anticipated Study Completion Date :
    Sep 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Suitability of a revised Manchester Triage System (MTS) [13 months (the revised MTS will be an output from the analysis of data collected months 1 - 13)]

      The suitability of a revised MTS to support identification and management of drug-related problems in the Emergency Department

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria: The following groups will be included in various stages of the project

    • STAGE A: ED clinicians at UK-wide NHS trusts

    • STAGE B: ED staff from 8 NHS sites across the UK

    • STAGE C: ED staff from 8 NHS sites across the UK

    • STAGE E: Clinicians and academics with expertise in Emergency Care and/or ED Triage

    • STAGE F: ED staff from 8 NHS sites across the UK

    Exclusion Criteria:
    • Those who do not consent or who are unable to consent

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Anglia Ruskin University
    • Pharmacy Research UK
    • University of Manchester
    • Ashford and St. Peter's Hospitals NHS Trust

    Investigators

    • Principal Investigator: Daniel Greenwood, Anglia Ruskin University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Anglia Ruskin University
    ClinicalTrials.gov Identifier:
    NCT05476705
    Other Study ID Numbers:
    • IRAS 307523
    First Posted:
    Jul 27, 2022
    Last Update Posted:
    Jul 27, 2022
    Last Verified:
    Jul 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Anglia Ruskin University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2022